Verdict № 009 · Sep 5, 2026 · updated Sep 8, 2026

IV Vitamin Drips, Dissected.

AI-researched · adversarially reviewed · human-checked · corrections public
BEFORE YOU READ — HOW DO YOU RULE?
The Verdict The IV vitamin drip solves a problem you don't have: a working gut already absorbs nutrients, and working kidneys promptly discard the surplus — bypassing digestion adds nothing but speed to the urine. There is no trial evidence for the immunity, energy, glow, or "optimization" claims, and the flagship cocktail failed its one controlled test. Meanwhile a needle breaches your skin in a storefront or hotel room, at prices real medicine would blush at. Actual IV therapy belongs in actual medicine: dehydration you can't drink through, deficiency, malabsorption, chemotherapy support.
Skip it
STRONG EVIDENCE
§ What it actually does

Where the evidence says yes

§ What it doesn't do

Where the marketing outruns the data

§ The Money Map

Who profits, stage by stage

The unit economicsSaline plus vitamins costs single-digit dollars; drips retail $150–$400. The margin funds the lounge chairs, the branding, and the influencer codes.
The medical costumeThe needle IS the marketing: an IV line signals seriousness that a tablet can't. The product borrows hospital credibility while operating in a med-spa regulatory gap, often physician-"supervised" from another zip code.
The franchise waveDrip bars are sold as low-overhead franchises with per-drip economics — growth is driven by outlet count and celebrity seeding, not by any outcome data.
The enforcement recordUS regulators have acted repeatedly: FTC action over deceptive treatment claims (iV Bars, 2018) and pandemic-era warnings over immunity-boost marketing. The claims retreat, the drips continue.
This pageNo drip bars, no franchise referrals, no supplement affiliates. See "How we make money."
§ The other side

The strongest case against this verdict

The strongest honest case for the drip bar: for acute misery — the migraine day, the gastro bug, the brutal hangover — rapid rehydration genuinely helps, urgent care would charge more with a four-hour wait, and buying it directly is a rational convenience purchase. Some clients (heavy drinkers, bariatric patients, the pregnant with severe nausea) hover near true depletion where parenteral topping-up is more than placebo. And the placebo itself is potent: an hour reclined, cared for, cannulated — the ritual delivers real felt benefit even when the vitamins are decoration. Sold as "fast fluids and comfort," honestly priced, it would be defensible. It is sold as optimization, which is why it's on this page.
§ Symmetric harms

Harms of using it — and of avoiding it

If you use it

  • Infection and phlebitis: every cannulation risks introducing bacteria — an accepted risk in hospitals treating illness, an unnecessary one in a mall treating wellness.
  • Fluid overload: a liter of saline is a genuine cardiac stress test for undiagnosed heart or kidney disease — screening at drip bars is a questionnaire.
  • Vitamin toxicity: fat-soluble overdoses accumulate; high-dose infusions have triggered kidney injury (oxalate from mega-dose vitamin C in susceptible patients).
  • Care substitution: "I got a drip" replacing actual evaluation of why you feel exhausted every week.
  • Money: a recurring $250 habit vs a $10 bottle of tablets the evidence rates identically for healthy guts.

If you avoid it

  • None for the healthy — skipping the drip bar costs nothing.
  • The medical exception matters: refusing clinically indicated IV therapy (severe dehydration, diagnosed deficiency, chemo support) because "drips are a scam" would be the error in the other direction. Context is the whole verdict.
§ The Minority Report

Who gets hurt when it goes right for everyone else

When an unnecessary product carries a needle, the hurt minority is defined by who shouldn't be cannulated:

How to tell if you might be in this group: Ask: has anyone measured a deficiency in me? Do I have heart/kidney disease or take regular medications? Am I buying this weekly for a symptom nobody has investigated? A yes to the last two is the exit sign.
§ The alternatives ledger

Everything else, judged by the same standards

strong A glass of water and food
For the healthy, pharmacokinetically equivalent to the drip at 1/500th the price. The gut is a world-class infusion device.
strong Oral supplements when a test shows deficiency
Test, then treat: the boring sequence that is actual medicine. Oral routes correct almost all deficiencies; injections/IV are for proven malabsorption.
strong Oral rehydration solution
The WHO-championed sachet that has saved millions of lives — superior science to any drip lounge, at pennies.
strong Sleep, and a fatigue workup if it persists
The evidence-based response to "I need energy" — and the one purchase no drip bar will ever suggest.
§ Take it to a human

Questions for your doctor

§ Sources, COI-flagged

Every claim, checkable

  1. rct Ali A, et al. (2009). Intravenous micronutrient therapy (Myers' Cocktail) for fibromyalgia: a placebo-controlled pilot study. J Altern Complement Med. Academic (Yale), sympathetic venue: both arms improved; no significant difference vs placebo — the industry's own flagship formula, tested and flat.
  2. opinion FTC (2018). iV Bars settles FTC charges of deceptive health claims for IV cocktails. US regulator enforcement record — claims about treating serious diseases withdrawn under settlement.
  3. opinion FDA/FTC (2020). Warning letters on IV "immunity" therapies marketed during COVID-19. Pandemic-era enforcement against immunity-boost drip marketing.
  4. mechanistic Padayatty SJ, et al. (2004). Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. NIH: the pharmacology showing tight renal control of vitamin levels — the mechanism behind "expensive urine."
  5. observational Prier M, et al. (2019). No reported renal safety with high-dose IV vitamin C except in susceptible patients (G6PD deficiency, renal impairment): review. Academic review defining exactly who the mega-dose minority-report groups are.
§ What we don't know

The honest uncertainty list

§ Corrections

Updates & corrections — public, dated, proud

No corrections yet. Found an error? Challenge it — substantiated challenges are corrected within 48 hours and logged here permanently. Submit a challenge →

§ We dissect ourselves too

How WE make money

This pageNo drip bars, no franchises, no supplement sellers. Health.AI earns from optional Pro subscriptions. If that changes, this box changes first.

Demand the next dissection

Any disease, drug, supplement, or practice. The queue decides what we dissect next.

How Dissected works

What is Dissected?

A free treatment auditor on health.ai. Type any drug, supplement, therapy, or procedure and get an honest verdict: what the evidence shows, what it doesn't, who gets hurt even when it works — and who profits at every stage. Pharmaceutical and natural treatments are held to the same standards: our homeopathy verdict and our stent verdict are equally blunt.

How to use it

  • Search any treatment from the top bar. If we've dissected it, you'll land on its verdict.
  • No verdict yet? Hit “Demand it.” The queue is public and demand decides what we dissect next — leave an email and you'll get the verdict the moment it publishes.
  • Rule first. Verdict pages ask for your call — Works / Overhyped / Doesn't work — before the reveal. It's optional (“Just show me” skips it), but it's the honest way to notice what the marketing has already done to you.
  • Play the daily game. Placebo or Not? — ten treatments, three buttons, one score. Same deck for everyone each day; share your 🟩🟥 grid and challenge someone.

How to read a verdict

  • The badge (Works, with catches Conditional Placebo) — our one-line finding.
  • The evidence meter — how solid the science behind the verdict is (strong / moderate / weak / unknown). A “Placebo” verdict can have strong evidence: we're very sure it doesn't work.
  • Tier chips on each claim — where it comes from: meta-analysis > trial > observational > opinion. Higher tier, harder to argue with.
  • 💰 The Money Map — who profits at every stage, including who funded the studies we cite. The wellness seller's margin gets audited alongside pharma's.
  • The Minority Report — who gets hurt even when the treatment works for most people, and how to tell if you might be in that group. We never let the 5% disappear into the 95%.
  • The other side — the strongest honest case against our own verdict, written to win. If we can't survive our own counterargument, we shouldn't publish.
  • Sources — every claim links to its study, and every study carries a 💰 COI flag telling you who paid for it.

Why trust it?

  • AI-researched, human-checked. Five adversarial research passes, then a person reads every verdict before it publishes.
  • No ads. No affiliates. Ever. We sell nothing on any verdict page, and every page discloses how we make money (optional Pro subscriptions to health.ai's AI tools).
  • Corrections are public. Substantiated errors get fixed within 48 hours and logged permanently on the page. Found one? Use the challenge link on any verdict.
  • Evidence-weighted, never popularity-weighted. Reader votes are compared against verdicts, never used to change them.

What Dissected is not

Not medical advice. Verdicts describe evidence about populations — they can't know your history, your medications, or your situation. Never start or stop a treatment because of this site: bring the “questions for your doctor” from any verdict to a qualified clinician instead.